Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 4.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | RSCH | |
|---|---|---|
Market Cap | 172.82B | 742B |
Volume | 592.2K | 29.45M |
Lot | 5.92K | 294.49K |
Turnover | 147.05M | 8.14B |
Average Price | 248.31 | 276.35 |
Value | 147.05M | 8.14B |
Indicative Equilibrium Price | 254 | 270 |
Indicative Equilibrium Volume | 10 | 103 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
